{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:14:04Z","timestamp":1793610844454,"version":"4.5.0"},"reference-count":213,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic &amp; Medicinal Chemistry"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.bmc.2023.117512","type":"journal-article","created":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T22:29:05Z","timestamp":1698877745000},"page":"117512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Harvesting phosphorus-containing moieties for their antibacterial effects"],"prefix":"10.1016","volume":"96","author":[{"given":"Manuela","family":"Vor\u00e1\u010dov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matej","family":"Zore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jari","family":"Yli-Kauhaluoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6084-684X","authenticated-orcid":false,"given":"Paula","family":"Kiuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bmc.2023.117512_b0005","first-page":"277","article-title":"The antibiotic resistance crisis: part 1: causes and threats","volume":"40","author":"Ventola","year":"2015","journal-title":"P&T"},{"key":"10.1016\/j.bmc.2023.117512_b0010","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(21)02724-0","article-title":"Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis","volume":"399","author":"Antimicrobial","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/j.bmc.2023.117512_b0015","doi-asserted-by":"crossref","first-page":"184","DOI":"10.5001\/omj.2019.37","article-title":"WHO global priority pathogens list: A bibliometric analysis of medline-pubmed for knowledge mobilization to infection prevention and control practices in Bahrain","volume":"34","author":"Asokan","year":"2019","journal-title":"Oman Med J"},{"key":"10.1016\/j.bmc.2023.117512_b0020","unstructured":"WHO. WHO publishes list of bacteria for which new antibiotics are urgently needed. Accessed 27 October 2023. https:\/\/www.who.int\/news\/item\/27-02-2017-who-publishes-list-of-bacteria-for-which-new-antibiotics-are-urgently-needed; 2017."},{"key":"10.1016\/j.bmc.2023.117512_b0025","doi-asserted-by":"crossref","first-page":"28171","DOI":"10.1039\/C9RA04518J","article-title":"Peptidoglycan pathways: there are still more!","volume":"9","author":"Helal","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117512_b0030","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1021\/acs.jmedchem.2c01827","article-title":"Fragment-to-lead medicinal chemistry publications in 2021","volume":"66","author":"Walsh","year":"2023","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0035","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3390\/pharmaceutics15010049","article-title":"A guide to in silico drug design","volume":"15","author":"Chang","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.bmc.2023.117512_b0040","doi-asserted-by":"crossref","first-page":"2155816","DOI":"10.1080\/14756366.2022.2155816","article-title":"Selected strategies to fight pathogenic bacteria","volume":"38","author":"Plotniece","year":"2023","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0045","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1016\/j.ijantimicag.2007.07.015","article-title":"Introduction: historical perspective and development of amoxicillin\/clavulanate","volume":"30","author":"Geddes","year":"2007","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2023.117512_b0050","doi-asserted-by":"crossref","unstructured":"P. Jorth K. McLean A. Ratjen et al. Evolved aztreonam resistance is multifactorial and can produce hypervirulence in Pseudomonas aeruginosa mBio. 8 2017 00517 17.","DOI":"10.1128\/mBio.00517-17"},{"key":"10.1016\/j.bmc.2023.117512_b0055","doi-asserted-by":"crossref","first-page":"7957","DOI":"10.1021\/acs.chemrev.1c00138","article-title":"Metallo-\u03b2-lactamases in the age of multidrug resistance: From structure and mechanism to evolution, dissemination, and inhibitor design","volume":"121","author":"Bahr","year":"2021","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2023.117512_b0060","doi-asserted-by":"crossref","first-page":"e28","DOI":"10.1016\/S1473-3099(20)30868-9","article-title":"The urgent need for metallo-\u03b2-lactamase inhibitors: an unattended global threat","volume":"22","author":"Mojica","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0065","unstructured":"Administration USFD. FDA approves new antibacterial drug. Accessed 27 October 2023. https:\/\/www.fda.gov\/news-events\/press-announcements\/fda-approves-new-antibacterial-drug; 2017."},{"key":"10.1016\/j.bmc.2023.117512_b0070","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1021\/acs.jmedchem.9b01518","article-title":"Discovery of taniborbactam (VNRX-5133): a broad-spectrum serine- and metallo-\u03b2-lactamase inhibitor for carbapenem-resistant bacterial infections","volume":"63","author":"Liu","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0075","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1080\/13543784.2018.1426745","article-title":"Cefiderocol: a novel siderophore cephalosporin","volume":"27","author":"Choi","year":"2018","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2023.117512_b0080","doi-asserted-by":"crossref","first-page":"16","DOI":"10.37201\/req\/s02.02.2022","article-title":"Mechanism of action of cefiderocol","volume":"35","author":"Soriano","year":"2022","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.bmc.2023.117512_b0085","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s40265-016-0545-8","article-title":"Review of eravacycline, a novel fluorocycline antibacterial agent","volume":"76","author":"Zhanel","year":"2016","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2023.117512_b0090","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.3390\/life12121949","article-title":"Plazomicin against multidrug-resistant bacteria: A Scoping Review","volume":"12","author":"Alfieri","year":"2022","journal-title":"Life"},{"key":"10.1016\/j.bmc.2023.117512_b0095","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s11739-021-02749-1","article-title":"Advances in novel antibiotics to treat multidrug-resistant gram-negative bacterial infections","volume":"16","author":"Matlock","year":"2021","journal-title":"Intern Emerg Med"},{"key":"10.1016\/j.bmc.2023.117512_b0100","first-page":"522","article-title":"New antimicrobial treatment options for severe Gram-negative infections","volume":"28","author":"Hetzler","year":"2022","journal-title":"Curr Opin Crit Care"},{"key":"10.1016\/j.bmc.2023.117512_b0105","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0119-2022","article-title":"New antibiotics for Gram-negative pneumonia","volume":"31","author":"Bassetti","year":"2022","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.bmc.2023.117512_b0110","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/QCO.0000000000000885","article-title":"Novel agents in development for multidrug-resistant Gram-negative infections: potential new options facing multiple challenges","volume":"35","author":"Arya","year":"2022","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0115","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2021.127799","article-title":"Recent advances in antibacterial agents","volume":"35","author":"Kong","year":"2021","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0120","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/s41429-023-00629-8","article-title":"Antibiotics in the clinical pipeline as of December 2022","volume":"76","author":"Butler","year":"2023","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bmc.2023.117512_b0125","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/antibiotics11060723","article-title":"Cefiderocol: Systematic review of mechanisms of resistance, heteroresistance and in vivo emergence of resistance","volume":"11","author":"Karakonstantis","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117512_b0130","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41426-018-0141-y","article-title":"Overexpression of OqxAB and MacAB efflux pumps contributes to eravacycline resistance and heteroresistance in clinical isolates of Klebsiella pneumoniae","volume":"7","author":"Zheng","year":"2018","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.bmc.2023.117512_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.medidd.2020.100063","article-title":"Development and clinical application of phosphorus-containing drugs","volume":"8","author":"Yu","year":"2020","journal-title":"Med Drug Discov"},{"key":"10.1016\/j.bmc.2023.117512_b0140","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.biochi.2022.07.011","article-title":"Biomembrane lipids: When physics and chemistry join to shape biological activity","volume":"203","author":"Ramos-Martin","year":"2022","journal-title":"Biochimie"},{"key":"10.1016\/j.bmc.2023.117512_b0145","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3892\/ijmm.2017.3036","article-title":"The crucial role of protein phosphorylation in cell signaling and its use as targeted therapy (Review)","volume":"40","author":"Ardito","year":"2017","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.bmc.2023.117512_b0150","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1007\/s11302-012-9305-8","article-title":"ATP synthesis and storage","volume":"8","author":"Bonora","year":"2012","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.bmc.2023.117512_b0155","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1002\/cmdc.201800693","article-title":"The role of the phosphorus atom in drug design","volume":"14","author":"Rodriguez","year":"2019","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117512_b0160","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1128\/CMR.00102-15","article-title":"Approved antiviral drugs over the past 50 years","volume":"29","author":"De Clercq","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2023.117512_b0165","article-title":"Drug discovery of nucleos(t)ide antiviral agents: dedicated to prof. Dr. Erik De Clercq on occasion of his 80th birthday","author":"Li","year":"202126923","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117512_b0170","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.889737","article-title":"Phosphonates and phosphonate prodrugs in medicinal chemistry: past successes and future prospects","volume":"10","author":"Krecmerova","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0175","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116289","article-title":"Bisphosphonates: The role of chemistry in understanding their biological actions and structure-activity relationships, and new directions for their therapeutic use","volume":"156","author":"Ebetino","year":"2022","journal-title":"Bone"},{"key":"10.1016\/j.bmc.2023.117512_b0180","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.bmc.2023.117512_b0185","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1053\/ctrv.2000.0170","article-title":"Chemistry, pharmacology and pharmacokinetics of N, N', N\u201c -triethylenethiophosphoramide (ThioTEPA)","volume":"26","author":"Maanen","year":"2000","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.bmc.2023.117512_b0190","doi-asserted-by":"crossref","unstructured":"A.R. Ahmed S.M. Hombal Cyclophosphamide (Cytoxan). A review on relevant pharmacology and clinical uses J Am Acad Dermatol. 1984;11:1115-1126.","DOI":"10.1016\/S0190-9622(84)80193-0"},{"key":"10.1016\/j.bmc.2023.117512_b0195","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1021\/acs.jcim.6b00519","article-title":"Structural isosteres of phosphate groups in the protein data bank","volume":"57","author":"Zhang","year":"2017","journal-title":"J Chem Inf Model"},{"key":"10.1016\/j.bmc.2023.117512_b0200","doi-asserted-by":"crossref","first-page":"5704","DOI":"10.1021\/acs.chemrev.6b00536","article-title":"Phosphonate biochemistry","volume":"117","author":"Horsman","year":"2017","journal-title":"Chem Rev"},{"key":"10.1016\/j.bmc.2023.117512_b0205","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2021.695128","article-title":"Editorial: Phosphonate chemistry in drug design and development","volume":"9","author":"Turhanen","year":"2021","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0210","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.4155\/fmc-2018-0591","article-title":"Phosphonate prodrugs: an overview and recent advances","volume":"11","author":"Heidel","year":"2019","journal-title":"Future Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0215","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1126\/science.166.3901.122","article-title":"Phosphonomycin, a new antibiotic produced by strains of streptomyces","volume":"166","author":"Hendlin","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117512_b0220","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1126\/science.166.3901.123","article-title":"Phosphonomycin: structure and synthesis","volume":"166","author":"Christensen","year":"1969","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117512_b0225","doi-asserted-by":"crossref","first-page":"3510","DOI":"10.1021\/jo00835a070","article-title":"A new synthesis of the antibiotic phosphonomycin","volume":"35","author":"Glamkowski","year":"1970","journal-title":"J Org Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0230","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1128\/CMR.00068-15","article-title":"Fosfomycin","volume":"29","author":"Falagas","year":"2016","journal-title":"Clin Microbiol Rev"},{"key":"10.1016\/j.bmc.2023.117512_b0235","doi-asserted-by":"crossref","first-page":"2082693","DOI":"10.1155\/2016\/2082693","article-title":"Fosfomycin: A first-line oral therapy for acute uncomplicated cystitis","volume":"2016","author":"Zhanel","year":"2016","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"10.1016\/j.bmc.2023.117512_b0240","doi-asserted-by":"crossref","first-page":"5744","DOI":"10.1128\/AAC.00402-12","article-title":"Experience with fosfomycin for treatment of urinary tract infections due to multidrug-resistant organisms","volume":"56","author":"Neuner","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0245","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S1473-3099(09)70325-1","article-title":"Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum \u03b2-lactamase producing, Enterobacteriaceae infections: a systematic review","volume":"10","author":"Falagas","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0250","first-page":"45","article-title":"Fosfomycin in infections caused by multidrug-resistant Gram-negative pathogens","volume":"32","author":"Ruiz Ramos","year":"2019","journal-title":"Rev Esp Quimioter"},{"key":"10.1016\/j.bmc.2023.117512_b0255","doi-asserted-by":"crossref","first-page":"42204","DOI":"10.1039\/C9RA08299A","article-title":"The intriguing biology and chemistry of fosfomycin: the only marketed phosphonate antibiotic","volume":"9","author":"Cao","year":"2019","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117512_b0260","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ijantimicag.2018.09.013","article-title":"Resistance to fosfomycin: mechanisms, frequency and clinical consequences","volume":"53","author":"Falagas","year":"2019","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.bmc.2023.117512_b0265","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s10096-011-1360-5","article-title":"Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates","volume":"31","author":"Samonis","year":"2012","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0270","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114924","article-title":"Acyloxymethyl and alkoxycarbonyloxymethyl prodrugs of a fosmidomycin surrogate as antimalarial and antibacterial agents","volume":"245","author":"Courtens","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0275","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.3390\/ph15121553","article-title":"Over 40 years of fosmidomycin drug research: a comprehensive review and future opportunities","volume":"15","author":"Knak","year":"2022","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.bmc.2023.117512_b0280","doi-asserted-by":"crossref","first-page":"6973","DOI":"10.1016\/j.bmcl.2011.09.123","article-title":"Antibacterial and antitubercular activity of fosmidomycin, FR900098, and their lipophilic analogs","volume":"21","author":"Uh","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0285","doi-asserted-by":"crossref","first-page":"6865","DOI":"10.3390\/molecules27206865","article-title":"The synthesis and evaluation of diethyl benzylphosphonates as potential antimicrobial agents","volume":"27","author":"Brodzka","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117512_b0290","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1080\/10426507.2015.1043048","article-title":"Bismuth(III) chloride mediated Michaelis-Arbuzov reaction: a facile synthesis of substituted arylphosphonates\/phosphinates and bioactivity evaluation","volume":"190","author":"Subramanyam","year":"2015","journal-title":"Phosphorus Sulfur"},{"key":"10.1016\/j.bmc.2023.117512_b0295","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1016\/j.bmc.2009.03.028","article-title":"Inhibition of tRNA-dependent ligase MurM from Streptococcus pneumoniae by phosphonate and sulfonamide inhibitors","volume":"17","author":"Cressina","year":"2009","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0300","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1126\/science.2814513","article-title":"Inhibition of a class C \u03b2-lactamase by a specific phosphonate monoester","volume":"246","author":"Pratt","year":"1989","journal-title":"Science"},{"key":"10.1016\/j.bmc.2023.117512_b0305","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1042\/bj2750793","article-title":"Phosphonate monoester inhibitors of class A \u03b2-lactamases","volume":"275","author":"Rahil","year":"1991","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2023.117512_b0310","doi-asserted-by":"crossref","first-page":"5869","DOI":"10.1021\/bi00140a024","article-title":"Mechanism of inhibition of the class C \u03b2-lactamase of Enterobacter cloacae P99 by phosphonate monoesters","volume":"31","author":"Rahil","year":"1992","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117512_b0315","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1042\/bj2960389","article-title":"Structure-activity relationships in the inhibition of serine \u03b2-lactamases by phosphonic acid derivatives","volume":"296","author":"Rahil","year":"1993","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2023.117512_b0320","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1021\/bi00167a015","article-title":"Characterization of covalently bound enzyme inhibitors as transition-state analogs by protein stability measurements: phosphonate monoester inhibitors of a \u03b2-lactamase","volume":"33","author":"Rahil","year":"1994","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117512_b0325","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0968-0896(97)00103-X","article-title":"Structure-activity studies of the inhibition of serine \u03b2-lactamases by phosphonate monoesters","volume":"5","author":"Li","year":"1997","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0330","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115473","article-title":"Metal binding pharmacophore click-derived discovery of new broad-spectrum metallo-\u03b2-lactamase inhibitors","volume":"257","author":"Yan","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0335","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.1021\/jm200587f","article-title":"Remarkable potential of the \u03b1-aminophosphonate\/phosphinate structural motif in medicinal chemistry","volume":"54","author":"Mucha","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0340","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114891","article-title":"Novel coumarin aminophosphonates as potential multitargeting antibacterial agents against Staphylococcus aureus","volume":"245","author":"Yang","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0345","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s11030-021-10242-2","article-title":"Synthesis and potent antimicrobial activity of novel coumarylthiazole alpha-aminophosphonates derivatives","volume":"26","author":"Litim","year":"2022","journal-title":"Mol Divers"},{"key":"10.1016\/j.bmc.2023.117512_b0350","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s00044-021-02815-5","article-title":"Synthesis and potential antimicrobial activity of novel alpha-aminophosphonates derivatives bearing substituted quinoline or quinolone and thiazole moieties","volume":"31","author":"Litim","year":"2022","journal-title":"Med Chem Res"},{"key":"10.1016\/j.bmc.2023.117512_b0355","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/cjoc.202100165","article-title":"Design and Synthesis of sulfanilamide aminophosphonates as novel antibacterial agents towards Escherichia coli","volume":"39","author":"Wang","year":"2021","journal-title":"Chin J Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0360","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2022.128695","article-title":"Natural aloe emodin-hybridized sulfonamide aminophosphates as novel potential membrane-perturbing and DNA-intercalating agents against Enterococcus faecalis","volume":"64","author":"Deng","year":"2022","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0365","doi-asserted-by":"crossref","DOI":"10.1016\/j.molstruc.2022.133553","article-title":"Microwave-assisted synthesis of novel sulfonamide-based compounds bearing \u03b1-aminophosphonate and their antimicrobial properties","volume":"1266","author":"Sabry","year":"2022","journal-title":"J Mol Struct"},{"key":"10.1016\/j.bmc.2023.117512_b0370","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1021\/acs.jmedchem.0c01292","article-title":"Bisphosphonates, old friends of bones and new trends in clinics","volume":"64","author":"Barbosa","year":"2021","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0375","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.joms.2017.08.019","article-title":"In vitro investigation of the antimicrobial effect of three bisphosphonates against different bacterial strains","volume":"76","author":"Ermer","year":"2018","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/j.bmc.2023.117512_b0380","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1021\/acs.jmedchem.8b01878","article-title":"discovery of lipophilic bisphosphonates that target bacterial cell wall and quinone biosynthesis","volume":"62","author":"Malwal","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0385","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1111\/bph.15251","article-title":"Bisphosphonates for delivering drugs to bone","volume":"178","author":"Sun","year":"2021","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.bmc.2023.117512_b0390","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1021\/jm0105326","article-title":"Osteoadsorptive bisphosphonate derivatives of fluoroquinolone antibacterials","volume":"45","author":"Herczegh","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0395","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1002\/bjs.4644","article-title":"Bisphosphonate-ciprofloxacin bound to Skelite\u2122 is a prototype for enhancing experimental local antibiotic delivery to injured bone","volume":"91","author":"Buxton","year":"2004","journal-title":"Br J Surg"},{"key":"10.1016\/j.bmc.2023.117512_b0400","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ejmech.2011.10.049","article-title":"Synthesis of osteotropic hydroxybisphosphonate derivatives of fluoroquinolone antibacterials","volume":"47","author":"McPherson","year":"2012","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0405","doi-asserted-by":"crossref","first-page":"6955","DOI":"10.1021\/jm801007z","article-title":"Linking bisphosphonates to the free amino groups in fluoroquinolones: preparation of osteotropic prodrugs for the prevention of osteomyelitis","volume":"51","author":"Houghton","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0410","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1021\/acs.jmedchem.6b01615","article-title":"Design, Synthesis, and antimicrobial evaluation of a novel bone-targeting bisphosphonate-ciprofloxacin conjugate for the treatment of osteomyelitis biofilms","volume":"60","author":"Sedghizadeh","year":"2017","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0415","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3390\/ijms24031985","article-title":"Real-time impedance-based monitoring of the growth and inhibition of osteomyelitis biofilm pathogen Staphylococcus aureus treated with novel bisphosphonate-fluoroquinolone antimicrobial conjugates","volume":"24","author":"Sedghizadeh","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117512_b0420","first-page":"e1774","article-title":"Exploring the structure, function of thiamine pyrophosphate riboswitch, and designing small molecules for antibacterial activity. Wiley Interdiscip Rev","author":"Wakchaure","year":"2023","journal-title":"RNA"},{"key":"10.1016\/j.bmc.2023.117512_b0425","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a003533","article-title":"Riboswitches: structures and mechanisms","volume":"3","author":"Garst","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/j.bmc.2023.117512_b0430","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3390\/antibiotics11091243","article-title":"A riboswitch-driven era of new antibacterials","volume":"11","author":"Giarimoglou","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117512_b0435","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1021\/acschembio.1c00880","article-title":"Subsite ligand recognition and cooperativity in the tpp riboswitch: implications for fragment-linking in rna ligand discovery","volume":"17","author":"Zeller","year":"2022","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2023.117512_b0440","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/v14020434","article-title":"Current trend in antiviral therapy for chronic hepatitis B","volume":"14","author":"Chien","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bmc.2023.117512_b0445","doi-asserted-by":"crossref","unstructured":"Q. Zhang Y. Peng J. Hou et al. An O-benzyl phosphonamidate prodrug of tenofovir for the treatment of hepatitis B virus infection J Med Chem. 2022;65:9493 6505.","DOI":"10.1021\/acs.jmedchem.2c00869"},{"key":"10.1016\/j.bmc.2023.117512_b0450","doi-asserted-by":"crossref","first-page":"4447","DOI":"10.3390\/molecules27144447","article-title":"Synthesis and evaluation of anti-HIV activity of mono- and di-substituted phosphonamidate conjugates of tenofovir","volume":"27","author":"Qureshi","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117512_b0455","doi-asserted-by":"crossref","first-page":"e0037822","DOI":"10.1128\/msphere.00378-22","article-title":"O-2-Alkylated cytosine acyclic nucleoside phosphonamidate prodrugs display pan-genotype antiviral activity against African swine fever virus","volume":"7","author":"Goulding","year":"2022","journal-title":"mSphere"},{"key":"10.1016\/j.bmc.2023.117512_b0460","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1042\/bj3140457","article-title":"Phosphonamidate analogues of dipeptides with carboxypeptidase A and \u03b2-lactamase-inhibitory activity: elucidation of the mechanism of \u03b2-lactamase inhibition by electrospray mass spectrometry","volume":"314","author":"Payne","year":"1996","journal-title":"Biochem J"},{"key":"10.1016\/j.bmc.2023.117512_b0465","doi-asserted-by":"crossref","first-page":"4550","DOI":"10.1021\/acsomega.1c06527","article-title":"Metallo-\u03b2-lactamase inhibitor phosphonamidate monoesters","volume":"7","author":"Palica","year":"2022","journal-title":"ACS Omega"},{"key":"10.1016\/j.bmc.2023.117512_b0470","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/14756366.2019.1681987","article-title":"Phosphonamidates are the first phosphorus-based zinc binding motif to show inhibition of \u03b2-class carbonic anhydrases from bacteria, fungi, and protozoa","volume":"35","author":"Alissa","year":"2020","journal-title":"J Enzyme Inhib Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0475","doi-asserted-by":"crossref","first-page":"e202100568","DOI":"10.1002\/cmdc.202100568","article-title":"Halogen-dance-based synthesis of phosphonomethoxyethyl (PME) substituted 2-aminothiazoles as potent inhibitors of bacterial adenylate cyclases","volume":"17","author":"Cesnek","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117512_b0480","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2021.113581","article-title":"Acyclic nucleoside phosphonates with 2-aminothiazole base as inhibitors of bacterial and mammalian adenylate cyclases","volume":"222","author":"Brehova","year":"2021","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0485","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/cmdc.201700715","article-title":"Synthesis of \u03b1-branched acyclic nucleoside phosphonates as potential inhibitors of bacterial adenylate cyclases","volume":"13","author":"Frydrych","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117512_b0490","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1002\/cmdc.201600439","article-title":"Design and synthesis of fluorescent acyclic nucleoside phosphonates as potent inhibitors of bacterial adenylate cyclases","volume":"11","author":"Brehova","year":"2016","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117512_b0495","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/cmdc.201500183","article-title":"Bisamidate prodrugs of 2-substituted 9-[2-(Phosphonomethoxy)ethyl]adenine (PMEA, adefovir) as selective inhibitors of adenylate cyclase toxin from Bordetella pertussis","volume":"10","author":"Cesnek","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117512_b0500","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1128\/AAC.01685-13","article-title":"Amidate prodrugs of 9-[2-(phosphonomethoxy)ethyl]adenine as inhibitors of adenylate cyclase toxin from Bordetella pertussis","volume":"58","author":"Smidkova","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0505","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/nrmicro2688","article-title":"The myriad roles of cyclic AMP in microbial pathogens: from signal to sword","volume":"10","author":"McDonough","year":"2011","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/j.bmc.2023.117512_b0510","doi-asserted-by":"crossref","first-page":"3190","DOI":"10.1038\/sj.emboj.7600800","article-title":"Structural basis for the interaction of Bordetella pertussis adenylyl cyclase toxin with calmodulin","volume":"24","author":"Guo","year":"2005","journal-title":"EMBO J"},{"key":"10.1016\/j.bmc.2023.117512_b0515","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001442","article-title":"JMM Profile: Bordetella pertussis and whooping cough (pertussis): still a significant cause of infant morbidity and mortality, but vaccine-preventable","volume":"70","author":"Fry","year":"2021","journal-title":"J Med Microbiol"},{"key":"10.1016\/j.bmc.2023.117512_b0520","doi-asserted-by":"crossref","first-page":"3242","DOI":"10.1073\/pnas.0306552101","article-title":"Selective inhibition of anthrax edema factor by adefovir, a drug for chronic hepatitis B virus infection","volume":"101","author":"Shen","year":"2004","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117512_b0525","doi-asserted-by":"crossref","first-page":"5855","DOI":"10.1016\/j.bmcl.2013.08.098","article-title":"New \u03b2-phospholactam as a carbapenem transition state analog: Synthesis of a broad-spectrum inhibitor of metallo-\u03b2-lactamases","volume":"23","author":"Yang","year":"2013","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0530","doi-asserted-by":"crossref","first-page":"6967","DOI":"10.1021\/jm400779n","article-title":"Inhibition of the Escherichia coli 6-oxopurine phosphoribosyltransferases by nucleoside phosphonates: potential for new antibacterial agents","volume":"56","author":"Keough","year":"2013","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0535","doi-asserted-by":"crossref","first-page":"8365","DOI":"10.1021\/acs.jmedchem.9b00182","article-title":"Plasmodium Purine Metabolism and Its Inhibition by Nucleoside and Nucleotide Analogues","volume":"62","author":"Cheviet","year":"2019","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0540","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.drudis.2020.02.008","article-title":"Acyclic nucleoside phosphonates as possible chemotherapeutics against Trypanosoma brucei","volume":"25","author":"Teran","year":"2020","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2023.117512_b0545","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.bmcl.2011.10.094","article-title":"Synthesis, characterization and activity of new phosphonate dipeptides as potential inhibitors of VanX","volume":"22","author":"Jia","year":"2012","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0550","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1016\/j.bmcl.2011.09.020","article-title":"Synthesis and activity study of phosphonamidate dipeptides as potential inhibitors of VanX","volume":"21","author":"Yang","year":"2011","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0555","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0960-894X(00)00186-4","article-title":"Phosphonamidate and phosphothioate dipeptides as potential inhibitors of VanX","volume":"10","author":"Yang","year":"2000","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0560","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1002\/pro.3819","article-title":"Molecular mechanisms of vancomycin resistance","volume":"29","author":"Stogios","year":"2020","journal-title":"Protein Sci"},{"key":"10.1016\/j.bmc.2023.117512_b0565","doi-asserted-by":"crossref","first-page":"11028","DOI":"10.1073\/pnas.96.20.11028","article-title":"VanX, a bacterial D-alanyl-D-alanine dipeptidase: resistance, immunity, or survival function?","volume":"96","author":"Lessard","year":"1999","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117512_b0570","series-title":"Aminophosphonic and aminophosphinic acids: Chemistry and biological activity","author":"Kukhar\u02b9","year":"2000"},{"key":"10.1016\/j.bmc.2023.117512_b0575","doi-asserted-by":"crossref","first-page":"25898","DOI":"10.1039\/D0RA04655H","article-title":"Phosphonopeptides containing free phosphonic groups: Recent advances","volume":"10","author":"Kafarski","year":"2020","journal-title":"RSC Adv"},{"key":"10.1016\/j.bmc.2023.117512_b0580","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.bmcl.2019.02.034","article-title":"Recent developments in the synthesis and applications of phosphinic peptide analogs","volume":"29","author":"Talma","year":"2019","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0585","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1002\/psc.2841","article-title":"Practical synthesis of novel phosphonopeptides containing Aib(P)","volume":"22","author":"Cervera-Villanueva","year":"2016","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bmc.2023.117512_b0590","doi-asserted-by":"crossref","first-page":"5894","DOI":"10.3390\/molecules25245894","article-title":"Synthetic methods of phosphonopeptides","volume":"25","author":"Xu","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117512_b0595","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/272056a0","article-title":"Phosphonopeptides, a new class of synthetic antibacterial agents","volume":"272","author":"Allen","year":"1978","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117512_b0600","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1128\/AAC.15.5.696","article-title":"Phosphonopeptides as antibacterial agents: mechanism of action of alaphosphin","volume":"15","author":"Atherton","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0605","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1128\/AAC.15.5.684","article-title":"Phosphonopeptides as antibacterial agents: alaphosphin and related phosphonopeptides","volume":"15","author":"Allen","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0610","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1128\/AAC.16.3.306","article-title":"Phosphonopeptides as antibacterial agents: metabolism and pharmacokinetics of alafosfalin in animals and humans","volume":"16","author":"Allen","year":"1979","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0615","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1128\/AAC.17.6.973","article-title":"Pharmacokinetics of alafosfalin, alone and in combination with cephalexin, in humans","volume":"17","author":"Allen","year":"1980","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0620","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1128\/AAC.20.4.470","article-title":"Antibacterial properties of alafosfalin combined with cephalexin","volume":"20","author":"Atherton","year":"1981","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0625","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1093\/jac\/14.4.309","article-title":"Recent developments in the field of phosphonic acid antibiotics","volume":"14","author":"Neuman","year":"1984","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0630","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.3390\/molecules25061445","article-title":"Phosphonopeptides revisited, in an era of increasing antimicrobial resistance","volume":"25","author":"Marrs","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/j.bmc.2023.117512_b0635","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1021\/jm00151a005","article-title":"Synthesis and structure-activity relationships of antibacterial phosphonopeptides incorporating (1-aminoethyl)phosphonic acid and (aminomethyl)phosphonic acid","volume":"29","author":"Atherton","year":"1986","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0640","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/ja.2015.77","article-title":"Conserved biosynthetic pathways for phosalacine, bialaphos and newly discovered phosphonic acid natural products","volume":"69","author":"Blodgett","year":"2016","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmc.2023.117512_b0645","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7164\/antibiotics.37.829","article-title":"Phosalacine, a new herbicidal antibiotic containing phosphinothricin. Fermentation, isolation, biological activity and mechanism of action","volume":"37","author":"Omura","year":"1984","journal-title":"J Antibiot"},{"key":"10.1016\/j.bmc.2023.117512_b0650","doi-asserted-by":"crossref","first-page":"9089","DOI":"10.1002\/anie.200703810","article-title":"Reassignment of the structure of the antibiotic A53868 reveals an unusual amino dehydrophosphonic acid","volume":"46","author":"Whitteck","year":"2007","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2023.117512_b0655","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1128\/AAC.01483-10","article-title":"The antibiotic dehydrophos is converted to a toxic pyruvate analog by peptide bond cleavage in Salmonella enterica","volume":"55","author":"Circello","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0660","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1039\/C8OB03079K","article-title":"Synthesis and biological activity of dehydrophos derivatives","volume":"17","author":"Jim\u00e9nez-Andreu","year":"2019","journal-title":"Org Biomol Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0665","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1021\/acsinfecdis.8b00307","article-title":"Enamide prodrugs of acetyl phosphonate deoxy-D-xylulose-5-phosphate synthase inhibitors as potent antibacterial agents","volume":"5","author":"Bartee","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0670","doi-asserted-by":"crossref","first-page":"4958","DOI":"10.1016\/j.bmc.2013.06.064","article-title":"Synthesis and biological evaluation of potential threonine synthase inhibitors: Rhizocticin A and plumbemycin A","volume":"21","author":"Gahungu","year":"2013","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0675","first-page":"573","article-title":"Structure of plumbemycin A and B, antagonists of L-threonine from Streptomyces plumbeus","volume":"41","author":"Park","year":"1977","journal-title":"Agric Biol Chem."},{"key":"10.1016\/j.bmc.2023.117512_b0680","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1007\/BF00249082","article-title":"an antifungal phosphono-oligopeptide of Bacillus subtilis ATCC 6633: biological properties","volume":"153","author":"Kugler","year":"1990","journal-title":"Arch Microbiol"},{"key":"10.1016\/j.bmc.2023.117512_b0685","doi-asserted-by":"crossref","first-page":"12175","DOI":"10.1073\/pnas.1500873112","article-title":"Discovery of phosphonic acid natural products by mining the genomes of 10,000 actinomycetes","volume":"112","author":"Ju","year":"2015","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.bmc.2023.117512_b0690","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/anie.201308363","article-title":"Use of a phosphonate methyltransferase in the identification of the fosfazinomycin biosynthetic gene cluster","volume":"53","author":"Gao","year":"2014","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bmc.2023.117512_b0695","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.1021\/jacs.2c00627","article-title":"Biosynthesis of argolaphos illuminates the unusual biochemical origins of aminomethylphosphonate and N\u03b5-hydroxyarginine containing natural products","volume":"144","author":"Zhang","year":"2022","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117512_b0700","first-page":"616","article-title":"Clindamycin binding to ribosomes revisited: foot printing and computational detection of two binding sites within the peptidyl transferase center","volume":"68","author":"Kostopoulou","year":"2013","journal-title":"Pharmazie"},{"key":"10.1016\/j.bmc.2023.117512_b0705","unstructured":"Murphy PB, Bistas KG, Le JK. Clindamycin. StatPearls. Treasure Island (FL). Accessed 27 October 2023. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK519574\/; 2023."},{"key":"10.1016\/j.bmc.2023.117512_b0710","first-page":"1134","article-title":"Management of severe acne vulgaris with topical therapy","volume":"16","author":"Stein Gold","year":"2017","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.bmc.2023.117512_b0715","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/jdv.13185","article-title":"Clindamycin phosphate 1.2% \/ tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris","volume":"29","author":"Ochsendorf","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.bmc.2023.117512_b0720","first-page":"190","article-title":"Pharmacokinetic studies of clindamycin phosphate","volume":"13","author":"DeHaan","year":"1973","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.bmc.2023.117512_b0725","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1093\/cid\/cit658","article-title":"Tedizolid: a novel oxazolidinone for Gram-positive infections","volume":"58","author":"Moellering","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0730","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-015-0060-3","article-title":"Tedizolid phosphate: a next-generation oxazolidinone","volume":"4","author":"Rybak","year":"2015","journal-title":"Infect Dis Ther"},{"key":"10.1016\/j.bmc.2023.117512_b0735","doi-asserted-by":"crossref","first-page":"3060","DOI":"10.1128\/AAC.00431-13","article-title":"In vitro, in vivo, and clinical studies of tedizolid to assess the potential for peripheral or central monoamine oxidase interactions","volume":"57","author":"Flanagan","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0740","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1358\/dot.2014.50.11.2233783","article-title":"Tedizolid phosphate for the treatment of acute bacterial skin and skin structure infections","volume":"50","author":"Gras","year":"2014","journal-title":"Drugs Today"},{"key":"10.1016\/j.bmc.2023.117512_b0745","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1016\/j.jiac.2022.03.020","article-title":"Long-term use of tedizolid for pulmonary nocardiosis","volume":"28","author":"Chomei","year":"2022","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0750","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3390\/antibiotics8030137","article-title":"Tedizolid versus linezolid for the treatment of acute bacterial skin and skin structure infection: a systematic review and meta-analysis","volume":"8","author":"Lan","year":"2019","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117512_b0755","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2023.115239","article-title":"Oxazolidinone: A promising scaffold for the development of antibacterial drugs","volume":"250","author":"Yuan","year":"2023","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0760","first-page":"734","article-title":"Moenomycin, a new antibiotic. I. Fermentation and isolation","volume":"5","author":"Wallhausser","year":"1965","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0765","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1039\/c001461n","article-title":"Moenomycin family antibiotics: chemical synthesis, biosynthesis, and biological activity","volume":"27","author":"Ostash","year":"2010","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmc.2023.117512_b0770","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1021\/ja4000933","article-title":"Tuning the moenomycin pharmacophore to enable discovery of bacterial cell wall synthesis inhibitors","volume":"135","author":"Gampe","year":"2013","journal-title":"J Am Chem Soc"},{"key":"10.1016\/j.bmc.2023.117512_b0775","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.diagmicrobio.2006.03.014","article-title":"Flavophospholipol use in animals: positive implications for antimicrobial resistance based on its microbiologic properties","volume":"56","author":"Pfaller","year":"2006","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0780","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1021\/cb4006744","article-title":"Moenomycin resistance mutations in Staphylococcus aureus reduce peptidoglycan chain length and cause aberrant cell division","volume":"9","author":"Rebets","year":"2014","journal-title":"ACS Chem Biol"},{"key":"10.1016\/j.bmc.2023.117512_b0785","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.bmcl.2014.04.041","article-title":"Development of bacterial transglycosylase inhibitors as new antibiotics: moenomycin A treatment for drug-resistant Helicobacter pylori","volume":"24","author":"Tseng","year":"2014","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0790","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.897578","article-title":"Combating multidrug-resistant Helicobacter pylori with moenomycin A in combination with clarithromycin or metronidazole","volume":"10","author":"Tseng","year":"2022","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0795","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1021\/acsinfecdis.1c00040","article-title":"A screen of natural product extracts identifies moenomycin as a potent antigonococcal agent","volume":"7","author":"Yarlagadda","year":"2021","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0800","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1093\/jac\/dkac202","article-title":"Moenomycin is broadly active against multidrug-resistant Neisseria gonorrhoeae and clears an infection from a murine vaginal tract infection model","volume":"77","author":"Yang","year":"2022","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b0805","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fimmu.2013.00078","article-title":"Peptidoglycan glycosyltransferase substrate mimics as templates for the design of new antibacterial drugs","volume":"4","author":"Derouaux","year":"2013","journal-title":"Front Immunol"},{"key":"10.1016\/j.bmc.2023.117512_b0810","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadva.2022.100065","article-title":"Structural diversity, bioactivity, and biosynthesis of phosphoglycolipid family antibiotics: Recent advances","volume":"2","author":"Ostash","year":"2022","journal-title":"BBA Adv"},{"key":"10.1016\/j.bmc.2023.117512_b0815","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112262","article-title":"Breaking down the cell wall: Strategies for antibiotic discovery targeting bacterial transpeptidases","volume":"194","author":"Cochrane","year":"2020","journal-title":"Eur J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0820","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1021\/acsinfecdis.9b00118","article-title":"Targeting the bacterial transglycosylase: antibiotic development from a structural perspective","volume":"5","author":"Chen","year":"2019","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0825","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1038\/2131092a0","article-title":"The prasinomycins: antibiotics containing phosphorus","volume":"213","author":"Weisenborn","year":"1967","journal-title":"Nature"},{"key":"10.1016\/j.bmc.2023.117512_b0830","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1128\/am.16.4.603-608.1968","article-title":"Biological characterization of prasinomycin, a phosphorus-containing antibiotic","volume":"16","author":"Meyers","year":"1968","journal-title":"Appl Microbiol"},{"key":"10.1016\/j.bmc.2023.117512_b0835","doi-asserted-by":"crossref","first-page":"8632","DOI":"10.1021\/jm2011673","article-title":"Phosphorodiamidates as a promising new phosphate prodrug motif for antiviral drug discovery: application to anti-HCV agents","volume":"54","author":"McGuigan","year":"2011","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0840","article-title":"Overview of biologically active nucleoside phosphonates","volume":"8","author":"Groaz","year":"2020","journal-title":"Front Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0845","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1517\/13543784.2013.775246","article-title":"Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection","volume":"22","author":"Herbst","year":"2013","journal-title":"Expert Opin Invest Drugs"},{"key":"10.1016\/j.bmc.2023.117512_b0850","first-page":"CD014962","article-title":"Remdesivir for the treatment of COVID-19","volume":"1","author":"Grundeis","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.bmc.2023.117512_b0855","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.15190\/d.2022.10","article-title":"Remdesivir: the first FDA-approved anti-COVID-19 treatment for young children","volume":"10","author":"Chera","year":"2022","journal-title":"Discoveries"},{"key":"10.1016\/j.bmc.2023.117512_b0860","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103012","article-title":"Synthesis and biological evaluation of aryl phosphoramidate prodrugs of fosfoxacin and its derivatives","volume":"89","author":"Munier","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0865","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1080\/10799893.2020.1752719","article-title":"In silico docking studies and synthesis of new phosphoramidate derivatives of 6-fluoro-3-(piperidin-4-yl)benzo[d]isoxazole as potential antimicrobial agents","volume":"40","author":"Sivala","year":"2020","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.bmc.2023.117512_b0870","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/1439-7633(20020902)3:9<874::AID-CBIC874>3.0.CO;2-V","article-title":"Aspartyl phosphonates and phosphoramidates: the first synthetic inhibitors of bacterial aspartate-semialdehyde dehydrogenase","volume":"3","author":"Cox","year":"2002","journal-title":"ChemBioChem"},{"key":"10.1016\/j.bmc.2023.117512_b0875","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1039\/B206199F","article-title":"A new synthesis of phosphoramidates: inhibitors of the key bacterial enzyme aspartate semi-aldehyde dehydrogenase","author":"Adams","year":"2002","journal-title":"Chem Commun"},{"key":"10.1016\/j.bmc.2023.117512_b0880","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1039\/np9961300029","article-title":"The DAP pathway to lysine as a target for antimicrobial agents","volume":"13","author":"Cox","year":"1996","journal-title":"Nat Prod Rep"},{"key":"10.1016\/j.bmc.2023.117512_b0885","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2019.103039","article-title":"Potential chemical transformation of phosphinic acid derivatives and their applications in the synthesis of drugs","volume":"90","author":"Abdou","year":"2019","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0890","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/j.drudis.2018.11.016","article-title":"Phosphinic acids: current status and potential for drug discovery","volume":"24","author":"Abdou","year":"2019","journal-title":"Drug Discov Today"},{"key":"10.1016\/j.bmc.2023.117512_b0895","doi-asserted-by":"crossref","DOI":"10.1016\/j.tet.2020.131251","article-title":"Synopsis of recent synthetic methods and biological applications of phosphinic acid derivatives","volume":"76","author":"Abdou","year":"2020","journal-title":"Tetrahedron"},{"key":"10.1016\/j.bmc.2023.117512_b0900","doi-asserted-by":"crossref","first-page":"11603","DOI":"10.1073\/pnas.92.25.11603","article-title":"Phosphinate analogs of D-, D-dipeptides: slow-binding inhibition and proteolysis protection of VanX, a D-, D-dipeptidase required for vancomycin resistance in Enterococcus faecium","volume":"92","author":"Wu","year":"1995","journal-title":"PNAS"},{"key":"10.1016\/j.bmc.2023.117512_b0905","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S1074-5521(97)90118-6","article-title":"Aldehyde and phosphinate analogs of glutathione and glutathionylspermidine: potent, selective binding inhibitors of the E. coli bifunctional glutathionylspermidine synthetase\/amidase","volume":"4","author":"Lin","year":"1997","journal-title":"Chem Biol"},{"key":"10.1016\/j.bmc.2023.117512_b0910","doi-asserted-by":"crossref","first-page":"377","DOI":"10.3390\/ph16030377","article-title":"Anti-tuberculosis Mur inhibitors: structural insights and the way ahead for development of novel agents","volume":"16","author":"Mehta","year":"2023","journal-title":"Pharmaceuticals."},{"key":"10.1016\/j.bmc.2023.117512_b0915","doi-asserted-by":"crossref","first-page":"12207","DOI":"10.1021\/bi015567m","article-title":"Biochemical characterization of a phosphinate inhibitor of Escherichia coli MurC","volume":"40","author":"Marmor","year":"2001","journal-title":"Biochemistry"},{"key":"10.1016\/j.bmc.2023.117512_b0920","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.bmcl.2005.09.086","article-title":"Design, synthesis and structure-activity relationships of new phosphinate inhibitors of MurD","volume":"16","author":"Strancar","year":"2006","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0925","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1002\/ardp.200600191","article-title":"Phosphinate inhibitors of UDP-N-acetylmuramoyl-L-alanyl-D-glutamate: L-lysine ligase (MurE)","volume":"340","author":"Strancar","year":"2007","journal-title":"Arch Pharm"},{"key":"10.1016\/j.bmc.2023.117512_b0930","doi-asserted-by":"crossref","first-page":"5150","DOI":"10.1016\/j.bmcl.2005.08.055","article-title":"Phosphinate, sulfonate, and sulfonamidate dipeptides as potential inhibitors of Escherichia coli aminopeptidase N","volume":"15","author":"Yang","year":"2005","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0935","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s00726-011-0920-4","article-title":"N-substituted aminomethanephosphonic and aminomethane-P-methylphosphinic acids as inhibitors of ureases","volume":"42","author":"Berlicki","year":"2012","journal-title":"Amino Acids"},{"key":"10.1016\/j.bmc.2023.117512_b0940","doi-asserted-by":"crossref","first-page":"5597","DOI":"10.1021\/jm100340m","article-title":"Computer-aided optimization of phosphinic inhibitors of bacterial ureases","volume":"53","author":"Vassiliou","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0945","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/ml500380f","article-title":"Bis(aminomethyl)phosphinic acid, a highly promising scaffold for the development of bacterial urease inhibitors","volume":"6","author":"Macegoniuk","year":"2015","journal-title":"ACS Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b0950","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s40265-017-0776-3","article-title":"Brigatinib: First Global Approval","volume":"77","author":"Markham","year":"2017","journal-title":"Drugs"},{"key":"10.1016\/j.bmc.2023.117512_b0955","doi-asserted-by":"crossref","first-page":"7081","DOI":"10.1021\/acs.jmedchem.0c00407","article-title":"Phosphine oxides from a medicinal chemist's perspective: physicochemical and in vitro parameters relevant for drug discovery","volume":"63","author":"Finkbeiner","year":"2020","journal-title":"J Med Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0960","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2023.106363","article-title":"Phosphine chalcogenides and their derivatives from red phosphorus and functionalized pyridines, imidazoles, pyrazoles and their antimicrobial and cytostatic activity","volume":"132","author":"Malysheva","year":"2023","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117512_b0965","doi-asserted-by":"crossref","first-page":"e2000217","DOI":"10.1002\/cbdv.202000217","article-title":"Synthesis, antimicrobial activity and molecular docking study of novel \u03b1-(diphenylphosphoryl)- and \u03b1-(diphenylphosphorothioyl)cycloalkanone oximes","volume":"17","author":"Jebli","year":"2020","journal-title":"Chem Biodivers"},{"key":"10.1016\/j.bmc.2023.117512_b0970","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/pauz.19870160603","article-title":"Quart\u00e4re Phosphoniumverbindungen gegen Bakterien und Pilze","volume":"16","author":"Pernak","year":"1987","journal-title":"Unserer Zeit"},{"key":"10.1016\/j.bmc.2023.117512_b0975","first-page":"1617","article-title":"Elektronenoptische Untersuchungen \u00fcber morphologische Ver\u00e4nderungen von Bakterien nach Einwirkung von Dodecyl-triphenyl-phosphonium-bromid","volume":"50","author":"Kelling","year":"1953","journal-title":"Medizinische"},{"key":"10.1016\/j.bmc.2023.117512_b0980","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1021\/acsinfecdis.2c00382","article-title":"Quaternary phosphonium compound unveiled as a potent disinfectant against highly resistant Acinetobacter baumannii clinical isolates","volume":"8","author":"Michaud","year":"2022","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b0985","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/cmdc.202000612","article-title":"Advancements in the development of non-nitrogen-based amphiphilic antiseptics to overcome pathogenic bacterial resistance","volume":"15","author":"Carden","year":"2020","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117512_b0990","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhazmat.2022.130393","article-title":"Quaternary ammonium compounds of emerging concern: Classification, occurrence, fate, toxicity and antimicrobial resistance","volume":"445","author":"Mohapatra","year":"2023","journal-title":"J Hazard Mater"},{"key":"10.1016\/j.bmc.2023.117512_b0995","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102304","article-title":"The silent pandemic: Emergent antibiotic resistances following the global response to SARS-CoV-2","volume":"24","author":"Mahoney","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.bmc.2023.117512_b1000","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jiph.2023.02.021","article-title":"A parallel and silent emerging pandemic: Antimicrobial resistance (AMR) amid COVID-19 pandemic","volume":"16","author":"Rehman","year":"2023","journal-title":"J Infect Public Health"},{"key":"10.1016\/j.bmc.2023.117512_b1005","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1128\/AAC.38.5.945","article-title":"Synthesis and antimicrobial activity of dimethyl- and trimethyl-substituted phosphonium salts with alkyl chains of various lengths","volume":"38","author":"Kanazawa","year":"1994","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.bmc.2023.117512_b1010","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1021\/acsinfecdis.2c00575","article-title":"Atom economical QPCs: phenyl-free biscationic quaternary phosphonium compounds as potent disinfectants","volume":"9","author":"Thierer","year":"2023","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b1015","doi-asserted-by":"crossref","first-page":"e202200224","DOI":"10.1002\/cmdc.202200224","article-title":"Rigidity-activity relationships of bisQPC scaffolds against pathogenic bacteria","volume":"17","author":"Spahr","year":"2022","journal-title":"ChemMedChem"},{"key":"10.1016\/j.bmc.2023.117512_b1020","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1021\/acsinfecdis.2c00624","article-title":"Soft QPCs: biscationic quaternary phosphonium compounds as soft antimicrobial agents","volume":"9","author":"Brayton","year":"2023","journal-title":"ACS Infect Dis"},{"key":"10.1016\/j.bmc.2023.117512_b1025","doi-asserted-by":"crossref","first-page":"86","DOI":"10.3390\/ijms23010086","article-title":"Sterically hindered quaternary phosphonium salts (QPSs): antimicrobial activity and hemolytic and cytotoxic properties","volume":"23","author":"Ermolaev","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.bmc.2023.117512_b1030","doi-asserted-by":"crossref","first-page":"491","DOI":"10.3390\/antibiotics11040491","article-title":"Theoretical and experimental studies of phosphonium ionic liquids as potential antibacterials of MDR Acinetobacter baumannii","volume":"11","author":"Metelytsia","year":"2022","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117512_b1035","doi-asserted-by":"crossref","first-page":"205","DOI":"10.3390\/antibiotics9040205","article-title":"Acinetobacter baumannii resistance: a real challenge for clinicians","volume":"9","author":"Vazquez-Lopez","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.bmc.2023.117512_b1040","doi-asserted-by":"crossref","DOI":"10.1016\/j.bioorg.2022.106030","article-title":"Synthesis, biological evaluation and structure-activity relationship of 2-(2-hydroxyaryl)alkenylphosphonium salts with potency as anti-MRSA agents","volume":"127","author":"Terekhova","year":"2022","journal-title":"Bioorg Chem"},{"key":"10.1016\/j.bmc.2023.117512_b1045","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmcl.2020.127234","article-title":"Design and synthesis of amphiphilic 2-hydroxybenzylphosphonium salts with antimicrobial and antitumor dual action","volume":"30","author":"Terekhova","year":"2020","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bmc.2023.117512_b1050","doi-asserted-by":"crossref","first-page":"e09533","DOI":"10.1016\/j.heliyon.2022.e09533","article-title":"A comparative evaluation of antibacterial activities of imidazolium-, pyridinium-, and phosphonium-based ionic liquids containing octyl side chains","volume":"8","author":"Hassan","year":"2022","journal-title":"Heliyon"},{"key":"10.1016\/j.bmc.2023.117512_b1055","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1021\/acsabm.2c00615","article-title":"Ionic liquids as biocompatible antibacterial agents: a case study on structure-related bioactivity on Escherichia coli","volume":"5","author":"Fernandes","year":"2022","journal-title":"ACS Appl Bio Mater."},{"key":"10.1016\/j.bmc.2023.117512_b1060","doi-asserted-by":"crossref","DOI":"10.1016\/j.jare.2023.02.004","article-title":"Phytochemicals and quaternary phosphonium ionic liquids: connecting the dots to develop a new class of antimicrobial agents","author":"Chavarria","year":"2023","journal-title":"J Adv Res"},{"key":"10.1016\/j.bmc.2023.117512_b1065","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.2147\/IJN.S398748","article-title":"Synthetic Antibacterial quaternary phosphorus salts promote methicillin-resistant Staphylococcus aureus-infected wound healing","volume":"18","author":"Shi","year":"2023","journal-title":"Int J Nanomed"}],"container-title":["Bioorganic &amp; Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0968089623003607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T01:23:21Z","timestamp":1760837001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0968089623003607"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":213,"alternative-id":["S0968089623003607"],"URL":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117512","relation":{},"ISSN":["0968-0896"],"issn-type":[{"value":"0968-0896","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Harvesting phosphorus-containing moieties for their antibacterial effects","name":"articletitle","label":"Article Title"},{"value":"Bioorganic & Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bmc.2023.117512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"117512"}}